things to avoid on semaglutide Foods Diet on semaglutide: complete guide

The opposing presynaptic and postsynaptic effects of NTS1 on striatal dopaminergic signaling complicate our understanding of NT's role in the modulation of striatal-mediated addictive behaviors

this is a personalized approach in coordination with a clinician

Recent research like the work happening at the University of Alabama at Birmingham (UAB) is helping explain why these medications are so effective and how they affect not just metabolism, but the brain itself

Eating feels like a chore

Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved

GLP-1RAs have shown similar promise in reducing nicotine cravings, in part due to their mitigation of the weight gain commonly associated with smoking cessation